60 Degrees Pharmaceuticals, Inc.
SXTP
$0.95
-$0.02-2.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.22M | 1.32M | 1.41M | 1.37M | 984.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.22M | 1.32M | 1.41M | 1.37M | 984.50K |
| Cost of Revenue | 3.22M | 2.76M | 2.83M | 2.81M | 2.51M |
| Gross Profit | -2.01M | -1.44M | -1.42M | -1.44M | -1.53M |
| SG&A Expenses | 6.60M | 6.50M | 6.34M | 6.47M | 6.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.82M | 9.26M | 9.17M | 9.27M | 8.69M |
| Operating Income | -8.61M | -7.94M | -7.76M | -7.91M | -7.70M |
| Income Before Tax | -8.11M | -7.58M | -7.37M | -7.98M | -7.82M |
| Income Tax Expenses | -1.50K | -1.50K | -1.50K | -500.00 | -500.00 |
| Earnings from Continuing Operations | -8.11 | -7.58 | -7.37 | -7.98 | -7.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.20K | 3.30K | 3.20K | 6.60K | 6.60K |
| Net Income | -8.11M | -7.58M | -7.37M | -7.97M | -7.82M |
| EBIT | -8.61M | -7.94M | -7.76M | -7.91M | -7.70M |
| EBITDA | -8.51M | -7.85M | -7.68M | -7.83M | -7.63M |
| EPS Basic | -6.32 | -10.46 | -15.40 | -23.03 | -39.01 |
| Normalized Basic EPS | -3.71 | -6.12 | -9.01 | -13.51 | -22.99 |
| EPS Diluted | -6.32 | -10.46 | -15.40 | -23.03 | -39.01 |
| Normalized Diluted EPS | -3.71 | -6.12 | -9.01 | -13.51 | -22.99 |
| Average Basic Shares Outstanding | 6.36M | 4.08M | 2.67M | 1.85M | 1.05M |
| Average Diluted Shares Outstanding | 6.36M | 4.08M | 2.67M | 1.85M | 1.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |